A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer
A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer
Colon Rectal Cancer Duke Stage Stageval
DRUG: Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®)
Evaluate the safety of pre-operative concurrent chemotherapy with capacitabine (Xeloda), weekly cetuximab (Erbitux), and external beam radiation., For the duration of the experiment
Evaluate efficacy of sphincter preserving surgery rate, local recurrence rate and the disease free and overall survival in patients., For the duration of the experiment
Its a pilot study of pre-op chemotherapy and RT utilizing CAPECITABINE, XRT and CETUXIMAB in pts with locally advanced rectal carcinoma.